Business · 24/10/2024Updated: 10/17/2026 · 1 min read
FDA Announces Public Advisory Committee Meeting on RSV Vaccine Safety
Summary
The FDA is hosting a public advisory committee meeting to discuss the safety of Respiratory Syncytial Virus (RSV) vaccines in pediatric populations, with at least one portion of the meeting closed to the public, and is seeking public comments on the topic.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →